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METHODOLOGY

Multi-year optimization of malaria
intervention: a mathematical model
Harry J. Dudley1, Abhishek Goenka2, Cesar J. Orellana2 and Susan E. Martonosi2*

Abstract
Background: Malaria is a mosquito-borne, lethal disease that a ects millions and kills hundreds of thousands of
people each year, mostly children. There is an increasing need for models of malaria control. In this paper, a model
is developed for allocating malaria interventions across geographic regions and time, subject to budget constraints,
with the aim of minimizing the number of person-days of malaria infection.
Methods: The model considers a range of several conditions: climatic characteristics, treatment e cacy, distribution
costs, and treatment coverage. An expanded susceptible-infected-recovered compartment model for the disease
dynamics is coupled with an integer linear programming model for selecting the disease interventions. The model
produces an intervention plan for all regions, identifying which combination of interventions, with which level of
coverage, to use in each region and year in a 5-year planning horizon.
Results: Simulations using the model yield high-level, qualitative insights on optimal intervention policies: The optimal intervention policy is di erent when considering a 5-year time horizon than when considering only a single year,
due to the e ects that interventions have on the disease transmission dynamics. The vaccine intervention is rarely
selected, except if its assumed cost is signi cantly lower than that predicted in the literature. Increasing the available
budget causes the number of person-days of malaria infection to decrease linearly up to a point, after which the
bene t of increased budget starts to taper. The optimal policy is highly dependent on assumptions about mosquito
density, selecting di erent interventions for wet climates with high density than for dry climates with low density, and
the interventions are found to be less e ective at controlling malaria in the wet climates when attainable intervention coverage is 60 % or lower. However, when intervention coverage of 80 % is attainable, then malaria prevalence
drops quickly in all geographic regions, even when factoring in the greater expense of the higher coverage against a
constant budget.
Conclusions: The model provides a qualitative decision-making tool to weigh alternatives and guide malaria eradication e orts. A one-size- ts-all campaign is found not to be cost-e ective; it is better to consider geographic variations
and changes in malaria transmission over time when determining intervention strategies.
Keywords: Malaria policy, Operations research, Compartment model, Integer programming
Background
Malaria remains a lethal disease a ecting an estimated
200 million people and killing 627,000 in 2012 [1]. ere
are a variety of interventions for treating or preventing
malaria infection, but the use of these interventions is
hindered by scarcity of resources. Mathematical models
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provide a useful tool for evaluating intervention strategies and studying the relative e ectiveness of interventions.
ese evaluations will become increasingly
useful as success with malaria elimination is predicted to
change transmission dynamics. In fact, the WHO Global
Malaria Programme cites the speci c need for operations
research models to determine the best intervention strategies in areas where transmission dynamics are changing
as malaria is being eliminated [2].
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In this paper, an integer linear program (ILP) and a
coupled susceptible-infected-recovered (SIR) compartment model are developed to create a decision-making
tool for planning future interventions.
e model suggests the best strategy for minimizing person-days of
malaria infection over a 5-year period given an initial
population, cost of each intervention, and a budget constraint. e model allows for the possibility of a malaria
vaccine in combination with other interventions. Simulations are performed in which the budget, the e cacy of
the interventions, and their cost are varied to determine
the sensitivity of the optimal policy to these parameters.
Interventions

ere are many existing methods to prevent or treat
malaria infection. e model will consider the following
ve interventions and their combinations.
Long-la sting insecticidal nets (LLINs) cover sleeping
individuals during the night when mosquito biting can
be highest. When intact, the nets block mosquitoes from
reaching humans.
e insecticides work by deterring
mosquitoes from feeding and by killing female mosquitoes that come in contact with the net. LLINs can remain
e ective for multiple years [3]. In fact, the WHO Pesticide Evaluation Scheme 2005 guidelines state that LLINs
should survive at least 3 years of recommended washing
and use [4].
Indoor residual spraying (IRS) is another insecticidal
prevention method. IRS is believed to deter mosquitoes
from entering sprayed areas and to kill female Anopheles
mosquitoes that rest on sprayed surfaces after feeding.
(Resting after feeding is a hallmark of some mosquito
species while others prefer to rest outdoors [5]). Historically, IRS with an insecticide called dichlorodiphenyltrichloroethane was e ective in reducing malaria in
Europe, Asia, and Latin America. However, as insecticide
use increases, insecticide resistance has been observed in
some mosquito populations in Africa, and new insecticides must be used [1].
Intermittent preventive therapy (IPT) is the regular
administration of a drug like sulfadoxine– pyrimethamnine to decrease morbidity due to malaria in infants, children, and pregnant women. IPT decreases the chance of
developing symptoms after being bitten by an infected
mosquito [6]. ere is evidence that children withstand
acute infection better than adults. However, in endemic
areas, adults develop acquired immunity from repeated
exposures, and children remain more susceptible to high
levels of parasitaemia (parasite density in the blood) [7].
Most of the 627,000 people killed by malaria in 2012 were
children in Africa, so giving IPT to infants, children, and
pregnant women treats the most vulnerable population
while limiting the risk of spreading drug resistance [1].
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Artemisinin combination therapy (ACT) can be used to
treat a patient after they contract malaria. is is the best
treatment for uncomplicated P. falciparum malaria when
con rmed by rapid diagnostic tests (RDT) [1, 8]. ACT
kills the parasites that cause symptoms and may destroy
or disable the gametocytes that are responsible for infecting mosquitoes [9]. Both these factors mean that ACT
increases the recovery rate.
Many malaria vaccines are in development, and one
has gone through Phase III clinical trials. e complex
life-cycle of the malaria parasite makes it possible to
intervene at many stages. Vaccines that target di erent
forms of the parasite will operate by di erent mechanisms, but in general, a vaccine would decrease the
chance of developing symptoms and increase the recovery rate if infected. e leading malaria vaccine candidate
is the RTS,S malaria vaccine. It is an antigen composed of
the RTS and S proteins. e RTS,S vaccine is a pre-erythrocytic vaccine that presents circumsporozoite protein
(CSP) from malaria sporozoites to the immune system.
CSP is a parasitic surface protein that is an important
part of the invasion of hepatocytes by sporozoites [10].
Such a vaccine will decrease the probability that a susceptible person becomes infected after a bite from an
infectious mosquito. Moreover, it is believed the vaccine
could increase a person’s recovery rate by increasing their
exposure to asexual blood-stage parasites, thereby boosting their immunity [10]. (By contrast, a transmissionblocking vaccine that acts in mosquitoes would decrease
the probability of transmission from an infectious mosquito but would not change the human recovery rate).
Literature review

is paper extends a single-stage optimization model of
Dimitrov et al. eir model divides the country of Nigeria into approximately 270,000 cells and chooses one
action (either a single intervention or no intervention)
for each cell over a year, subject to budget constraints, to
minimize societal costs caused by malaria infection. e
model also identi es optimal locations for supply distribution centres. ey treat the societal bene t of each
intervention as an exogenous parameter that depends
on geographic characteristics. is allows their model to
consider geographic variability in malaria dynamics [11].
However, because malaria dynamics depend on the fraction of the population that is infectious, a quantity that the
interventions are themselves trying to reduce, the framework of Dimitrov et al. does not permit the examination
of multiyear e orts against malaria in which the optimal
policy might vary over time as the malaria dynamics shift.
is paper extends the optimization model above to select
interventions (or combinations thereof) over multiple
years by explicitly incorporating malaria disease dynamics
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over time in response to those interventions.
is is a
novel approach that combines two areas of mathematics
that do not regularly interact: ILP from the area of operations research and di erential equations modelling from
the area of mathematical epidemiology.
ere is a long history of mathematical models of
malaria transmission, going back to the work of Sir
Ronald Ross in the early 1900s [12, 13]. In recent years,
malaria has drawn signi cant attention from the academic
community. Epidemiologists have traditionally modelled
the spread of malaria in a population using variations on
the SIR model to capture di erent aspects of the disease.
Mandal et al. survey the models found in the literature
and o er a hierarchy based on model complexity [13].
In order for the model presented here to make informed
choices about which interventions to distribute, the
dynamics of how disease transmission change after
treatment interventions must rst be understood. Lindblade et al. and Killeen et al. study the protective e ect
of insecticide-treated nets or LLINs [16]. Bousema et al.
investigate how ACT reduces the circulation time of
gametocytes, thereby reducing infectiousness [16]. Garner and Graves examine the community bene ts of ACT
[17]. Chandramohan et al., Grobusch et al., and Aponte et
al. quantify the protective e ects of IPT for infants [6, 18,
19]. Pluess et al. review the e ects of IRS [5]. ese results
are used to inform the model’s choice of disease transmission parameters, as described later under “E ects of interventions on SIR parameters” section.
e model presented here includes in its portfolio of
interventions a vaccine that is currently in development.
Prosper et al. model the interaction between vaccine- and
naturally-acquired immunity using a ve-compartment
model. eir model augments the S, I, and R classes with
a partially-immune (due either to vaccination or natural
immunity) susceptible class and a moderately-infectious
class for infected, partially-immune individuals.
ey
nd that disease burden can be decreased only if a highly
e ective vaccine is coupled with a policy of actively treating asymptomatic infections in partially immune individuals [20]. Bojang et al. report there is minimal potential
e ect for a malaria vaccine given to adult men, and
Asante et al. study the positive potential protective bene ts of administering the vaccine to children [21, 22].
ere are extensions to the SIR framework that are not
considered here. Koella and Antia model the reduced
e cacy of interventions due to the spread of drugresistant strains of malaria [23].
e model presented
here does not incorporate drug-resistance, so any policy
recommended by the model should be evaluated in this
context. Other researchers, for example Dawes et al. [24]
and Koudou et al. [25], focus on the mosquitoes’ plasmodial transmission dynamics by analysing the e ects of
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interventions on mosquito morbidity and mortality rates
and the usefulness of the resulting manipulation of said
rates.
e changing mosquito population is not modelled explicitly; instead the e ects of interventions on the
mosquito population are represented as changes in the
parameter values used in the human SIR model.
While the above references provide detailed models of
malaria’s complex dynamics, this paper presents a simple SIR model that accommodates the e ects of several
types of interventions, while maintaining the computational tractability required by the optimization model. In
the next section, the model and simulation approach are
described in greater detail.

Methods
is paper considers the problem of allocating malaria
treatments to many regions when limited by scarce
resources. ere is assumed to be a xed annual budget
shared across several geographic regions having di erent
initial incidences and transmission rates of malaria and
di erent unit costs for distributing treatment. A portfolio of interventions can be selected, including some
in combination, each having its own e ects on malaria
transmission. Each intervention is selected at a particular
coverage, which is the percentage of the population that
receives the intervention and uses it correctly. Social and
economic losses are assumed to be proportional to the
time spent infectious, so person-days of malaria infection
is the chosen measure of the malaria burden. e model
identi es the optimal sequence of interventions and corresponding coverage percentages for each region and
each year that minimizes the total infected person-days
over a xed time horizon.
An integer linear programming optimization model
(ILP) suggests the best set of interventions in each year to
minimize person-days of malaria infection over all time
steps. e ILP takes as input the number of person-days
of malaria infection that occur when a given intervention
is used on a population with a given initial prevalence
of malaria. e person-days of malaria infection is estimated by a SIR di erential equations model of malaria
transmission dynamics.
Integer linear programming (ILP) model

e ILP relies on several sets, parameters, and decision
variables, which are de ned here.
Sets

Geographic regions Because the cost of distributing an
intervention to a particular district depends on its infrastructure and ease of access to treatment, and the malaria
transmission dynamics depend on its climate, districts
are grouped into geographic regions, denoted by index g.
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e optimization model determines the number of districts in each geographic region to receive a particular
sequence of interventions.
Population states A population state, p, is a triplet,
(S, I, R), that indicates the percentage of a district’s population susceptible to (S), infected by (I), or recovered from
and temporarily immune to (R) malaria. Each district
begins a year in a particular population state and ends in
a new population state that depends on how the chosen
intervention a ects the malaria disease dynamics. ( e
model for determining the disease progression is described
in the “Di erential equations (DE) model” section).
Actions e set of actions is the set of possible choices
of intervention (including certain combinations of interventions, or the possibility of applying no intervention).
e choice of intervention at a determined coverage level
in a district is referred to as an action, denoted by index i.
Parameters

Ain
igpq

Aout
igp

Bt

Cig
I pg

Lipg

N
T

is an indicator variable whose value is 1 if
action i applied to a district of geographic
region g, initially in population state p causes
a transition to population state q, and 0
otherwise.
is an indicator variable whose value is 1 if
action i applied to a district of geographic
region g, initially in population state p causes a
transition to a di erent population state, and 0
otherwise.
is the annual budget for year t; the combined
cost of actions across all districts in year t
must not exceed this value.
is the cost of action i in any district in geographic region g.
is the number of districts in geographic region
g that are initially in population state p at the
rst time step.
is the number of person-days of malaria infection incurred in a district in geographic region
g, initially in population state p, under action i.
is a number larger than the total number of
population states.
is the time horizon, in years, considered by the
model.

Decision variables

Ppgt

is the number of districts in geographic region
g that are initially in population state p at the
start of year t.
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aOUT
ipgt

is the number of districts in geographic region
g that are initially in population state p at the
start of year t and are assigned action i.
is the number of districts in geographic region
g that are initially in population state p at the
start of year t, are assigned action i, and end in
population state q.

aIN
ipqgt

Model

Using these sets, parameters and decision variables, the
following ILP can now be de ned.

LipgaOUT
ipgt

min

(1)

t ,i,p,g

s.t .

aOUT
ipgt ≤ Bt

Cig

t

(2)

p

i,g

Pp,g,t = 1 = I pg

p, g

Ppgt =

Pp,g,t + 1

p

(3)
g, t

(4)

p

aOUT
ipgt = Ppgt

p,g,t

(5)

i

aIN
ipqgt −

Ppgt +
i,q

OUT
aIN
ipqgt = aiqgt

aOUT
ipgt = Pp,g,t + 1
i

i,q,g,t

p, g, t

(6)

(7)

p
in
aIN
ipqgt ≤ N · Aigpq

i,p,q,g,t

(8)

out
aOUT
ipgt ≤ N · Aigp

i,p,g,t

(9)

OUT
Ppgt , aIN
ipqgt , aipgt ≥ 0, integer

i, p, q, g, t

e objective function in expression (1) minimizes the
cumulative person-days that each district spends in
the infected state over the time horizon, as a function
of the model’s choice of actions. Constraint (2) requires
the chosen set of interventions to be within budget in
each year. Constraint (3) initializes the population variable at the start of the time horizon. Constraints (4), (5),
(6) and (7) are bookkeeping constraints that keep track
of the number of districts in each geographic region
and population state as a function of the actions chosen. Constraints (8) and (9) assure that districts transition out of population state p to population state q only
when an appropriate action has been taken.
e last
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constraint requires all decision variables to be nonnegative integers.
Di erential equations (DE) model

Several of the parameters used by the ILP model, speout
ci cally Ain
igpq, Aigp and Lipg depend on the dynamics of
malaria progression. e SIR model is a standard system
of nonlinear ordinary di erential equations for analysing the transmission of malaria [13, 23]. In this paper,
the standard model is modi ed to use a coupled six-class
compartment model with separate SIR compartments
for treated and untreated individuals.
is coupling of
treated and untreated SIR classes permits modelling of
population-wide bene ts caused by decreased infectiousness of a treated subpopulation. For an initial population state and action, this system of equations is solved
to determine the population state after 1 year. is yields
out
the indicator parameters Ain
e solution to
igpq and Aigp .
this system of di erential equations is also used to estimate the burden of malaria, measured in infected person-days, during that year. For each district in geographic
region g, beginning the year in a particular population
state p, having been assigned action i, the infected class
curve that results under those conditions is numerically
integrated, multiplied by the district’s population.
is
estimates the number of people who are infected over
the year times the number of days for which they remain
infected. is number is then input into the linear programming model as the value of Lipg. is is pre-solved
for all possible population states and actions, and the
results are stored as input data for the ILP.
e parameters, state variables and system of di erential equations are now de ned.
Parameters

au (at )

bu (bt )

c
δ
γu (γt)

hu (ht )

is the number of bites per mosquito per
untreated (respectively, treated) human per
day.
is the transmission e cacy from infected
mosquito to susceptible, untreated (resp.,
treated) human.
is the transmission e cacy from infected
human to susceptible mosquito.
is the daily birth rate and death rate. Constant
population is assumed.
is the recovery rate for untreated (resp.,
treated) people. Its reciprocal is the average
time that a person is infected with malaria.
is the force of infection, that is, the rate at
which untreated (resp., treated) susceptible
humans become infected with malaria.
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mu (mt )
µ
ω

q

ρu (ρt)
τ

is the number of mosquitoes per untreated
(resp., treated) human.
is the mosquito mortality rate.
is the duration of immunity without
reinfection.
is the treatment coverage, the percentage of
the population that receives a treatment and
uses it correctly. It is assumed that the same
percentage of newborns are born into the susceptible, treated class. e remaining fraction,
1 − q, are born into the susceptible, untreated
class.
is rate of immunity loss for recovered
untreated (resp., treated) humans.
is the incubation period of malaria in the
mosquito.

State variables

Su (St )
I u (I t )

Ru (Rt )

is the proportion of the population that is susceptible and untreated (resp., treated).
is the proportion of the population that is
symptomatic, infectious, and untreated (resp.,
treated).
is the proportion of the population that
is recovered with acquired immunity and
untreated (resp., treated).

Model

e proportions of the population belonging to each of
the six classes can be determined by solving the following
system of di erential equations:

dSu
= δ(1 − q) − (δ+ hu )Su + ρu Ru
dt

(10)

dI u
= hu Su − (δ+ γu )I u
dt

(11)

dRu
= γu I u − (δ+ ρu )Ru
dt

(12)

dSt
= δq − (δ+ ht )St + ρt Rt
dt

(13)

dI t
= ht St − (δ+ γt )I t
dt

(14)

dRt
= γt I t − (δ+ ρt )Rt .
dt

(15)

Although on the surface, the equations for the untreated
population and the equations for the treated population
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do not appear to be coupled, the coupling occurs with
the parameters hu and ht , which are the force of infection parameters. ey have been derived by Smith and
McKenzie [26] to be:

hu =

mu a2u bu ce− µ τ (I u + I t )
µ + au c(I u + I t )

(16)

ht =

mt a2tbt ce− µ τ (I u + I t )
.
µ + at c(I u + I t )

(17)

Observe that these rates are functions of the total proportion of infectious people, I u + I t , which couples the
system of di erential equations.
e more infectious
people there are in either the untreated or treated group,
the faster the rate at which susceptible people in either
group can become infected.
e rates of immunity loss, ρu and ρt, are functions of
hu and ht , respectively and further couple the system. e
procedure for deriving the rate of immunity loss has been
shown by Aron and May [27]. ese equations assume
that being exposed to malaria while recovering resets the
duration of immunity.

ρu =

hu + δ
eω(hu + δ) − 1

(18)

ρt =

ht + δ
eω(ht + δ) − 1

(19)

is is a general model that does not consider the e ect
an intervention can have on the transmission of the disease. In the speci c case of ACT, a medication that clears
infection rapidly, the length of time a malaria patient is
carrying infectious gametocytes in her blood is signi cantly reduced [16, 28]. Because of this, the model makes
the assumption that ACT clears parasites before the
body has time to develop acquired immunity; therefore,
infected people treated with ACT are assumed to skip the
recovered class and transition directly back to the susceptible class. To re ect this, the indicator variable ψ act is
introduced, which equals 1 when ACT is chosen (either
alone or in combination with another intervention), and
0 otherwise. e state equations for the untreated class
are unchanged, and the equations for the treated classes
become:

dSt
= δq − (δ+ ht )St + ρt Rt + ψact γt I t
dt

(20)

dI t
= ht St − (δ+ γt )I t
dt

(21)

dRt
= (1 − ψact )γt I t − (δ+ ρt )Rt
dt

(22)

Observe that when ACT is used, infectious individuals
bypass the recovered class and transition directly to the
susceptible class.
Because a new portfolio of interventions is selected
each year, the e ects of treatment are assumed to last for
1 year, exactly. Some of the treatments are known to last
longer; for instance, the insecticide coating on mosquito
nets is believed to be e ective for 3 years, and vaccines in
development currently have an e cacy of 3 years. However, assuming a duration of only 1 year is conservative:
under this assumption, the model will underestimate the
e cacy of the interventions, and the results expected to
be seen in the eld should be better. Under this assumption, at the end of each year, the six-state population
(Su ,I u ,Ru ,St ,I t ,Rt )can be collapsed into a more compact
three-state representation: (Su + St ,I u + I t ,Ru + Rt ).
Coverage

e coverage, q, refers to the percentage of the population that receives a treatment and uses it correctly. For
example, if at the start of the year, the percentages of the
population who are susceptible, infected and recovered
are given by (S, I, R), respectively, then the initial values
of Su ,I u ,Ru ,St ,I t , and Rt for the di erential equations
model will be (1 − q)S, (1 − q)I , (1 − q)R, qS, qI , and qR,
respectively.
However, some interventions, such as IPT and vaccine, are assumed to be distributed only to newborns
and children under the age of four. In these cases, the
coverage, q, applies only to births and to the fraction of
the population under the age of four. If x is the fraction
of the population under the age of four, and (S, I, R) is
the initial distribution of susceptible, infected and recovered individuals in the population, then the initial values
of Su ,I u ,Ru ,St ,I t , and Rt for the di erential equations
model will be (1 − qx)S, (1 − qx)I , (1 − qx)R, qxS, qxI ,
and qxR.
Data

e model relies on parameters governing intervention
costs, malaria transmission, and intervention e cacy.
When available, parameter values are estimated based
on malaria research literature. When using country-speci c information, data from Kenya or its neighbours are
used as it is more readily available and permits consistency across parameters. is paper also presents sensitivity analysis to understand how the model’s results would
change under a range of scenarios concerning distribution costs, climate and intervention e cacy. In this section, the costs of the interventions are described rst,
followed by the baseline parameter values used in the
SIR model. en, the changes in these parameter values
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under interventions and sensitivity analysis scenarios are
described.
Base costs of interventions

e model parameter Cig is the per person, per year
cost of action i in any district in geographic region g.
e cost of an action depends on the purchase price as
well as transportation and distribution costs, which are
assumed to be regional. For the base cost, the simulations
use data provided by White et al., who survey cost and
cost-e ectiveness data for LLIN, IRS, IPT, and ACT from
all available sources and adjust it to 2009 USD [29]. e
simulations primarily use data from Kenya, except where
noted that no Kenya-speci c data was available; in these
cases, cost estimates from nearby Ethiopia, Tanzania and
Zimbabwe are used.
Listed here are the base costs for each intervention; the
subsequent section describes how to modify those costs
to re ect transportation and distribution costs in di erent geographic regions. ese are summarized in Table 1.
LLIN
e average cost of a single insecticide-treated
mosquito net is 7.21 USD [29], and the WHO Pesticide
Evaluation Scheme 2005 guidelines estimate a 3 year
life span with recommended use [4]. Because the model
assumes all actions expire at the end of 1 year, an annual
cost per net of 2.40 USD is used, which is one-third the
base cost of the net. Moreover, bed-sharing is a common
practice that further reduces the per-person cost of each
distributed net. e World Health Organization recommends the assumption that an LLIN will protect 1.8 people, on average [30], making the annual per-person cost
1.33 USD.
IRS
e IRS cost estimate assumes two rounds of
household spraying with lambda cyhalothrin per person
per year, at an annual cost of 2.22 USD [29].
IPT White et al. summarize cost estimates for distributing IPT to newborns, children and pregnant women.
e mean cost of distributing six bi-monthly doses of
sulfadoxine– pyrimethamine to infants in Tanzania is
reported to be 0.78 USD, and three doses per year to

children in Kenya is 1.25 USD [29]. As roughly 25 % of
children under the age of 4 are infants, the simulations
use an estimated weighted average annual cost for IPT of
1.13 USD.
ACT White et al. report malaria diagnosis and treatment costs for a variety of diagnostic methods and treatment types in several countries. For consistency, the
simulation uses costs associated speci cally with RDT
used in conjunction with ACT treatment in the countries
of Tanzania and Zambia.
ese range from 3.63 USD
to 6.72 USD, with an average of 4.82 USD per person
treated [29]. Unlike interventions such as LLINs, which
are assumed to be distributed to the entire treated class,
ACT is distributed only to members of the treated class
who experience a malaria infection.
erefore, the SIR
model must estimate the number of new malaria infections per year to determine the annual cost of ACT.
According to Eq. (21), new infections occur with rate
dI t
t
ht St = dI
dt + (δ+ γt )I t . Note that dt can be approximated
I t (d)
for small ǫ. Discretizing the year over
by I t (d+ ǫ)−
ǫ
which the treatment is available into 365 days and letting
ǫ = 1 day, the number of new infections appearing on day
d should be roughly I t (d) − (1 − (δ+ γt ))I t (d − 1) times
the total population. Summing this value over all days
d should give an approximation of the number of new
infections incurred during the year, and hence, the number of people who received ACT.
Vaccine Cost data for the RTS,S vaccine is not yet available since the vaccine is not yet on the market. Seo et al.
use an estimate of 7 USD per dose for the vaccine after
looking at recent introductory vaccine prices ranging
from 1 to 15 USD [31]. ey also propose using 0.37 USD
administration cost per vaccination based on the price
for other vaccines used in Malawi in the Expanded Program on Immunization (EPI). Because the RTS,S vaccine
is administered in three doses, they estimate the total
cost of the vaccine at 22.11 USD per person per year [31].
Adjusting their 2012 costs to 2009 values for consistency
yields a cost of 20.66 USD per treated person per year
[32].

Baseline SIRmodel parameter values
Table 1 Baseline cost for using interventions, per treated
person for 1 year, in 2009 USD [29–31]
Intervention

Cost

None

0

LLIN

1.33

ACT

4.82

IPT

1.13

IRS

2.22

Vaccine

20.66

e baseline parameter values used in the SIR model are
now described; the following section discusses how the
interventions and modelling assumptions a ect those
values. is information is summarized in Table 2.
• au is the number of bites per mosquito per untreated
human per day, which is estimated to be 0.25 [33].
• bu is the transmission probability from infected mosquito to susceptible, untreated human, which is estimated to be 0.022 [33].
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Table 2 Malaria transmission parameter values for the baseline, untreated case (corresponding to the subscript “ u” )
and treatment cases (corresponding to the subscript “ t” )
Symbol Description

Baseline value
(untreated)

Treatment value

au(1 − β) [15]

LLIN

au, at

Bites per mosquito per human per day

0.25 [33]

bu, bt

Transmission e cacy from infected mosquito to
susceptible, untreated human

0.022 [33]

β

Proportion of bites that would occur while sleeping

c

Transmission e cacy from infected human to
mosquito

0.36 [33]

δ

Daily birth rate and death rate assuming constant
population

4.7895 ∗ 10− 5 [34]

γu, γt

Recovery rate in humans

1
180 [35]

mu, mt

Mosquitoes per human

20 [13]

µ

Mosquito mortality rate

0.095 [35, 36]

ω

Duration of immunity without reinfection

274 days [37]

q

Treatment coverage

0.2, 0.4 or 0.6

τ

Incubation period in mosquito

10 days [36]

x

Fraction of the population

0.146 [34]

IRS

IPT

ACT Vaccine

0.0047

0.005

0.8 [15]

1
10

1
5.5

mu(1 − βχ LLIN) mu,IRS = mu(1 − qχ IRSu )
mt = mu(1 − χ IRSt ) [38]

0–4 years of age
χLLIN

Probability of mosquito mortality when exposed to
a treated net

χIRSt

Percent reduction in mosquito density in a house
treated with IRS

0.95 [38]

χIRSu

Percent reduction in mosquito density in an
untreated house when all nearby houses are
treated with IRS

0.5 [38]

0.8 [14]

In the baseline value column, an empty space means that the parameter does not apply to the baseline, untreated case. In the treatment value columns, an empty
space means that the parameter is unchanged by that particular intervention

• c is the transmission probability from infected human
to susceptible mosquito, which is estimated to be
0.36 [33].
• δ is the daily birth rate and death rate. In Kenya in
2014, the estimated annual birth rate was 0.02827
births per person, and the estimated annual death
rate was 0.007 deaths per person [34]. Because the
model assumes a constant population, the average
of these, or 0.017635 births (deaths) per person per
year, is converted using compounding to a daily birth
(death) rate of δ = 4.7895 × 10− 5.
• γu is the recovery rate for untreated people. Filipe et al. estimate the average infectious period for
1
untreated people to be 180 days, making γu = 180
[35].
• mu is the mosquito density (number of mosquitoes per
untreated human), which is estimated to be 20 [13].
• µ is the mosquito mortality rate, estimated to be
0.095 days− 1 [35, 36].

• ω is the duration of immunity without reinfection.
e value ω = 274 days, is based on an estimate that
immunity lasts between 6 and 12 months [37].
• q is the treatment coverage, the percentage of the
population that receives a treatment and uses it correctly.
ree levels of treatment coverage for each
intervention are considered: high (60 %), medium
(40 %), and low (20 %).
• τ is the incubation period in the mosquito, estimated
to be 10 days [36].
• x is the fraction of the population that is age 4 years
or younger, which was approximately 14.6 % in Kenya
in 2014 [34].
e expressions given in Eqs. (16), (17), (18) and (19) are
used to determine the force of infection (hu and ht ) and
the recovery rate (ρu and ρt).
Note that the malaria transmission parameters, au, bu,
c, and mu, are very location-speci c (see [36], p. 409).
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Adapting this model to any location would require reestimating these parameters.
E ects of interventions on SIRparameters

Each intervention, or combination of interventions, is
modelled as a ecting a subset of the above parameters.
LLINs protect individual users by decreasing the biting
rate, at , and by killing mosquitoes that contact the insecticidal nets, thus decreasing mt . e values of at and mt
are estimated as follows:
• Let β be the proportion of mosquito exposure that
occurs during sleeping hours.
• Let χLLIN be the probability of mortality for a mosquito exposed to a treated net.
• As before, let mu be the baseline mosquito density
absent any treatment.
en Killeen et al. [15] derive the value of at for people
using LLIN as

at = au (1 − β),

(23)

and the value of mt for people using LLIN as

mt = mu (1 − βχ LLIN ).

(24)

Although Fig. 5 in reference [15] shows a slight increase in
overall protection for the treated class as a function of q,
this increase is modest in the range of q considered here,
and so mt is assumed to be independent of q. Additionally,
Killeen et al. suggest that as treatment coverage increases
in a population, even non-users of LLINs bene t from
decreased mosquito density. However, the authors were
unable to nd empirical data to support a robust model
of mosquito density in the untreated population as a function of treatment coverage; therefore, the model assumes
that the untreated population experiences the baseline
mosquito density, mu, for all values of q.
To determine the new biting rate, at , and the new
mosquito density, mt , for the treated classes, Eqs. (23)
and (24), respectively, are used with β = 0.8 [15] and
χLLIN = 0.8 [14], and with au = 0.25, and mu = 20 as
given earlier.
IRS decreases the number of mosquitoes per treated
human, mt , in a similar manner as LLINs. Moreover, IRS
can also decrease the mosquito density in untreated areas
close to treated areas; thus, mu is also a ected by IRS
[38]. Let χIRSt be the reduction in mosquito density in a
house treated with IRS, and let χIRSu be the reduction in
mosquito density in an untreated house when the treatment coverage is 100 % in a nearby area. en the value
of mt for a house treated with IRS is

mt = mu (1 − χ IRSt )

(25)

e value of mu when IRS is used at coverage q is estimated (based on the empirical results of Zhou et al. [38])
to be

muIRS = mu (1 − qχ IRSu ).

(26)

As [38] report that the mosquito density in treated areas
decreases by 95 %, and the mosquito density in untreated
areas decreases by 50 % when the coverage in nearby
treated areas is 100 %, the simulations use χIRSt = 0.95
and χIRSu = 0.5, mu = 20 as given earlier, and q equal to
the coverage associated with the selected action.
IPT decreases the probability, bt , that a susceptible
person becomes infected after a bite from an infectious mosquito. The authors were unable to find an
estimate in the literature for the amount by which
the transmission efficacy, bt , decreases when a person is using IPT. However, data from several studies
reported by Aponte et al. indicate that the protective
efficacy against malaria in infants of 1 year of IPT is
roughly 30 % [6]. As this should roughly correspond
to the percentage decrease in new malaria infections
obser ved in the SIR model output, the model was calibrated by solving the system of differential equations
for a range of values for bt and selecting the value of
bt that achieves a 30 % reduction in new malaria infections. The value bt = 0.0047 achieves this percentage
reduction.
ACT dramatically reduces the length of time a malaria
patient is carrying infectious gametocytes in her blood,
possibly down to a mean infectious period of 10 days, so
1
the simulations use γt = 10
days− 1 [16, 17, 28].
Vaccine, like IPT, decreases the probability, bt , that a
susceptible person becomes infected after a bite from
an infectious mosquito. Additionally, a vaccine could
increase the recovery rate, γt, by exposing the immune
system to parasite proteins or decreasing the amount of
parasites that reach the blood stage initially [10]. Olotu
et al. report clinical trial results suggesting that the
4-year reduction in malaria episodes among vaccinated
children is 23.5– 24.3 % [39]. As this should roughly
correspond to the percentage decrease in new malaria
infections observed in the SIR model output, the model
was calibrated by solving the system of di erential equations for a range of values for both bt and γt and selecting
the combination that achieves a roughly 24 % reduction in new malaria infections. Choosing bt = 0.005 and
1
γt = 5.5
days− 1 achieves this percentage reduction.
Possible actions that can be selected by the optimization model are to deploy no intervention, a single
intervention, or a combination of two interventions.
Although it is possible to consider combining any pair
of interventions, for modelling simplicity, the only pairs
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of interventions considered are those whose coverage
applies to the same segments of the population. erefore, because IPT and vaccines are assumed in the model
to be distributed only to newborns and children under
the age of four, while LLIN, ACT and IRS are applied to
the general population, the combinations considered are
IPT with vaccine, LLIN with ACT, LLIN with IRS, or
ACT with IRS.
When two interventions are used in combination, it
is assumed that the covered segment of the population
receives both treatments, and the uncovered segment
receives neither. If the two interventions a ect non-overlapping parameter sets, it is assumed the combination
intervention will a ect the union of both sets of parameters in the same manner as the individual interventions.
However, some pairs of interventions act upon the same
parameter. For example, in the case of LLIN combined
with IRS, the mosquito density, mt is a ected by both
interventions. Because it would be too optimistic to
assume that the e ects of LLIN and IRS are additive, the
model makes a more conservative assumption: the smallest values of at , mu and mt o ered by either LLIN or IRS
are used. For the IPT with vaccine combination, bt , the
transmission e cacy from infected mosquito to susceptible, treated human, is reduced by both interventions via
di erent mechanisms, and γt is increased by the vaccine.
erefore, the smaller of the two bt values under IPT and
vaccine (that given by IPT, of bt = 0.0047) and the value
1
of γt = 5.5
yielded by the vaccine are used.
Sensitivity analysis simulations

e optimal sequence of 5-year interventions in a ctitious nation were simulated and analysed.
is nation
consists of 4500 districts, each having a population of
10,000 (for a total population of 45 million, comparable to that of Kenya in 2014 [34]). An annual budget of
Bt = 33.75 million USD is used, which corresponds to
0.75 USD per person, per year. ( is is comparable to
the budget for the President’s Malaria Initiative (PMI) in
Kenya, which in 2013 was 34,256,770 USD [40]).
Each of the 4500 districts is characterized as belonging
to one of nine geographic regions, which in turn are characterized by one of three distribution regions and one of
three climate regions. 500 districts belong to each of the
nine possible combinations. Distribution regions categorize districts by how inexpensively (relative to the baseline costs given earlier) interventions can be distributed
to the district. Rural and remote areas are likely to experience higher-than-baseline distribution costs due to having worse road infrastructure and lower access to health
centres. Centrally located urban areas are likely to experience lower-than-baseline distribution costs. Districts
categorized as having low distribution costs are assumed
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to have intervention costs that are 20 % lower than the
baseline values given in Table 1. Districts categorized as
having medium distribution costs will incur the baseline
intervention costs, and districts categorized as having
high distribution costs will incur intervention costs that
are 20 % more than the baseline costs given in Table 1.
e three climate regions, dry, moderate and wet,
re ect the e ect climatic characteristics such as temperature and precipitation can have on mosquito population,
and hence on malaria transmission dynamics. e moderate climate scenario assumes the baseline mosquito
density given above of mu = 20 mosquitoes per human
e dry scenario assumes a mosquito density of mu = 5
mosquitoes per human, and the wet scenario assumes a
mosquito density of mu = 35 mosquitoes per human.
Each region is also characterized by its own initial population distribution amongst the S, I and R classes, which
is chosen to be the steady-state population distribution
observed when the SIR model is run for a long period of
time from a variety of starting population distributions
and assuming no intervention. For the moderate climate
scenario, the steady-state distribution used for the initial distribution is 15 % susceptible, 15 % infected, and
70 % recovered. e dry scenario uses an initial steadystate distribution of 60 % susceptible, 15 % infected, and
25 % recovered. e wet scenario uses an initial steadystate population distribution of 10 % susceptible, 15 %
infected, and 75 % recovered. (For computational tractability, a population state resolution of ve percentiles
is used, and the SIR population state is rounded to the
nearest 5 %, while requiring that the percentages over all
compartments sum to one).
ree e cacy scenarios are also considered to test the
sensitivity of the model to the inherent uncertainty in the
e cacy of the interventions.
e baseline e cacy scenario uses the baseline parameter estimates described
earlier and shown in Table 2. e pessimistic e cacy scenario assumes each parameter value for the treated class
is 30 % “worse” than its baseline value, where “worse”
means leading to greater malaria infections. e optimistic e cacy scenario assumes each parameter value for
the treated class is 30 % “better” than its baseline value.
In the case where making a treatment parameter 30 %
worse than its baseline value ends up making it worse
than the untreated baseline value, the value is capped at
the untreated baseline; in this way, a situation is avoided
in which the treated class might arti cially experience
more malaria cases than the untreated class.

Results and discussion
e results of running the model on this data are now
presented. Because a simpli ed SIR model is used to
estimate the social costs of malaria as a function of
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interventions distributed, the purpose of this model is
not to give exact estimates of reductions in person-days
of malaria infection, but relative results that can be used
by the optimization model to make choices between the
various interventions.
e model provides qualitative
insights about trends in the optimal interventions as certain parameters vary; these qualitative insights can then
be used to o er high-level policy recommendations, as
described below.
Table 3 and Fig. 1 provide the sequence of interventions
allocated in each of the nine geographic regions (low,
medium or high distribution costs, crossed with dry,
moderate or wet climate) over a 5-year horizon in the
baseline e cacy case. e total person-days of malaria
infection is found to be 4.506 billion. In Fig. 1, the rst
row of gures corresponds to low distribution costs, the
second row to medium distribution costs and the third
row to high distribution costs. Likewise, each column of
gures corresponds to the same climate region (dry in
red, moderate in yellow, wet in blue, from left to right).
e vertical axis on each graph lists in alphabetical order
the interventions selected by the model at least once in at
least one geographic region and the associated coverage.
e thickness of a path is proportional to the number of
districts (out of 500) that were assigned that sequence
of interventions. Table 3 gives the number of districts of
each type that are assigned a particular sequence of interventions, as well as the resulting (S, I, R) population state
after each year.
Note that for dry climate regions, the sequence of
interventions is the same regardless of distribution cost,
namely, ACT is distributed to 60 % of the population in
year 1, and then no subsequent interventions are distributed in years 2– 5. e reason for this is that distributing
ACT at a coverage of 60 % in year 1 eradicates (at least
subject to rounding at a resolution of 5 %) malaria, driving the infected proportion of the population to zero.
Per Eqs. (16) and (17), the force of infection is zero when
the infected population is zero, and the disease cannot
persist.
For the moderate climate regions, all districts are
assigned ACT combined with LLIN at 60 % coverage
in the rst year, followed by ACT in combination with
either LLIN or IRS at 60 % coverage in subsequent years.
e sequence of interventions assigned in the wet
regions at rst glance appears more interesting. First,
note that only low distribution cost districts, along with
only two medium distribution cost and one high distribution cost districts, receive any intervention during
the rst year. 126 high distribution cost districts never
receive any intervention in any of the 5 years.
is is
likely due to the budget constraint forcing the model to
prioritize eliminating malaria in the dry climate regions
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during year 1 and leaving the harder-to-access wet
regions largely untreated. In those wet districts receiving interventions, the chosen interventions are primarily
LLIN with ACT at 60 % coverage, but as Table 3 shows,
these interventions do little to reduce the prevalence of
malaria in the population. An apparent steady-state consists of 10 % of the population in the infected state even
after several years of 60 % coverage of LLIN with ACT.
us, it can be inferred that combating malaria in the wet
regions is not possible with the interventions considered
at coverage percentages up to 60 %. As will be shown
later, increasing the maximum coverage to 80 % is necessary for reducing malaria in wet regions.
E ect of treatment e cacy

e sequence of interventions allocated in the nine
geographic regions under the optimistic and pessimistic e cacy scenarios, in which the disease transmission
parameter values for the treated class are adjusted up or
down by 30 %, can also be examined. e optimistic case
is depicted in Fig. 2, with the full set of results given in
Table 4, and the results for the pessimistic case are given
in Fig. 3 and Table 5.
In the optimistic case, note a reduction in person-days
of malaria infection from 4.506 billion to 2.977 billion, or
34 %. In year 1, the model focuses on eradicating (subject to rounding error) malaria in the dry and moderate
climate regions by allocating LLIN, ACT or the two in
combination. All but seven of the 1,500 wet climate districts receive no intervention in year 1. In subsequent
years, the wet climate districts receive 60 % coverage of
LLIN with ACT, and ACT with IRS, with a handful of wet
climate districts receiving IPT or no intervention during years 1 and 2. Although it appears that the dry and
moderate regions are also receiving interventions during
years 2 through 5, this is an artifact of the optimization
model: once the infectious population is driven to zero,
there is no value in distributing further interventions; the
model is allocating interventions in these regions simply
to use up the available budget. Moreover, the prevalence
of malaria in the wet regions appears to stabilize around
10 % in year 5. is is further indication that 60 % coverage is not su cient to diminish malaria prevalence in the
wet regions, even if the interventions are assumed to be
highly e ective.
In the pessimistic case, note an increase in person-days
of malaria infection from 4.506 billion to 5.080 billion, or
13 %. In year 1, resources are focused on rapidly reducing
infections in the dry regions, by allocating 60 % coverage
of ACT; remaining resources in year 1 are focused on the
moderate climate regions. In subsequent years, the moderate regions receive 60 % coverage of ACT combined
with either IRS or LLIN; the remaining budget is used
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Table 3 Optimal 5-year (Y1 through Y5) sequences of interventions for the baseline e cacy scenario
Geographic
region

Number of
districts

Initial
population state

Y1 intervention
(end pop. state)

Y2 intervention
(end pop. state)

Y3 intervention
(end pop. state)

Y4 intervention
(end pop. state)

Y5 intervention
(end pop. state)

(D, L)

500

(60, 15, 25)

ACT 60 %

None

None

None

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 60 %

None

None

None

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 60 %

None

None

None

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

ACT_IRS60 %

ACT_IRS60 %

(65, 5, 30)

(80, 5, 15)

(85, 5, 10)

(85, 5, 10)

(85, 5, 10)

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

ACT_IRS60 %

LLIN_ACT 60 %

(65, 5, 30)

(80, 5, 15)

(85, 5, 10)

(85, 5, 10)

(75, 10, 15)

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

ACT_IRS60 %

LLIN_ACT 60 %

(65, 5, 30)

(80, 5, 15)

(85, 5, 10)

(85, 5, 10)

(75, 10, 15)

LLIN_ACT 20 %

ACT_IRS60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(25, 10, 65)

(65, 5, 30)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

None

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

None

LLIN_ACT 20 %

ACT_IRS60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(25, 10, 65)

(65, 5, 30)

(60, 10, 30)

(60, 10, 30)

None

None

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

None

None

None

LLIN 20 %

LLIN_ACT 60 %

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(25, 10, 65)

(55, 10, 35)

None

None

IPT 40 %

LLIN 20 %

LLIN_ACT 60 %

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(25, 10, 65)

(55, 10, 35)

None

IPT 40 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

IPT 20 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

IPT 40 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

None

None

None

None

LLIN_ACT 60 %

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

None

None

None

None

None

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

None

None

None

None

IPT 40 %

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

None

None

IPT 40 %

None

LLIN_ACT 60 %

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

IPT 40 %

IPT 40 %

IPT 40 %

IPT 20 %

LLIN_ACT 60 %

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(D, M)
(D, H)
(M, L)
(M, M)
(M, H)
(W, L)
(W, L)
(W, M)
(W, M)
(W, M)
(W, M)
(W, M)
(W, M)
(W, M)
(W, M)

500
500
500
500
500
395
105
276
136
59
22
3
2
1
1

(60, 15, 25)
(60, 15, 25)
(15, 15, 70)
(15, 15, 70)
(15, 15, 70)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)

(W, H)

371

(10, 15, 75)

(W, H)

126

(10, 15, 75)

(W, H)
(W, H)
(W, H)

1
1
1

(10, 15, 75)
(10, 15, 75)
(10, 15, 75)

Geographic region refers to the climate region and distribution cost pair, where the climate region is dry (D), moderate (M) or wet (W), and the distribution cost is low
(L), medium (M) or high (H). Number of districts refers to the number of districts that were assigned a given trajectory. Initial population state is the starting (S, I, R)
percentages of the region; the end population state for a given year is the resulting (S, I, R) state after distributing the corresponding intervention. The total persondays of malaria infection in this scenario is 4.506 billion
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Low Distn. Cost, Dry Climate

Low Distn. Cost, Moderate Climate

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

1

2

3
Year

4

5

Medium Distn. Cost, Dry Climate
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

1

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
2

3
Year

4

5

2

3
Year

4

5

High Distn. Cost, Dry Climate

1

3
Year

4

5

1

3
Year

4

5

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
2

3
Year

4

5

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
2

2

Medium Distn. Cost, Wet Climate

1

High Distn. Cost, Moderate Climate

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
1

1

Medium Distn. Cost, Moderate Climate
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

1

Low Distn. Cost, Wet Climate

2

3
Year

4

5

High Distn. Cost, Wet Climate
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

2

3
Year

4

5

1

2

3
Year

4

5

Fig. 1 Sequence of interventions over a 5-year time horizon in the baseline e cacy scenario. The thickness of each line is proportional to the number of districts assigned a given sequence. Intervention sequences assigned to only a single district have been omitted from the gure ( ve districts
omitted in total). The total person-days of malaria infection in this scenario is 4.506 billion

to allocate a variety of interventions in the wet regions.
e takeaway message here is that to minimize persondays of malaria infection, the model chooses to focus
resources on the dry and moderate climate regions; any
remaining budget is allocated to the wet regions.
E ect of coverage

If a maximum coverage of 80 % (including both distribution and compliance) is attainable, the results change
dramatically. Table 6 gives the sequence of interventions
assuming a baseline e cacy and possible coverage levels
of 40 %, 60 and 80 % (rather than 20, 40 and 60 % used
earlier), and using the same annual budget of 33.75 million USD. In all geographic regions, the infected population is driven to zero within 2 years, indicating that

malaria is e ectively eradicated (at least subject to rounding at a resolution of 5 %). us, achieving high coverage is crucial to rapid eradication of malaria, even with
the annual budget held constant. Although intervention
costs rise in proportion to the treatment coverage, the
xed budget is able to achieve markedly lower persondays of malaria infection when 80 % coverage is achievable as opposed to only 60 % (1.139 billion person days,
as opposed to 4.506 billion person days,) although some
of this e ect is likely due to rounding at resolution 5 %.
us, giving a smaller number of cities a higher coverage
is more e ective than giving a larger number of cities a
lower coverage. Moreover, it is only when 80 % coverage
is attainable that the prevalence of malaria is reduced in
the wet climate regions.
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Low Distn. Cost, Dry Climate

Low Distn. Cost, Moderate Climate

ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None

ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None

1

2

3
Year

4

5

Medium Distn. Cost, Dry Climate
ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None

1

ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None
2

3
Year

4

5

2

3
Year

4

5

High Distn. Cost, Dry Climate

1

3
Year

4

5

1

3
Year

4

5

ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None
2

3
Year

4

5

ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None
2

2

Medium Distn. Cost, Wet Climate

1

High Distn. Cost, Moderate Climate

ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None
1

1

Medium Distn. Cost, Moderate Climate
ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None

1

Low Distn. Cost, Wet Climate

2

3
Year

4

5

High Distn. Cost, Wet Climate
ACT 20%
ACT 40%
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
LLIN 60%
LLIN_ACT 60%
None

2

3
Year

4

5

1

2

3
Year

4

5

Fig. 2 Sequence of interventions over a 5-year time horizon in the optimistic e cacy scenario. The thickness of each line is proportional to the
number of districts assigned a given sequence. Intervention sequences assigned to only a single district have been omitted from the gure (four
districts omitted in total). The total person-days of malaria infection in this scenario is 2.977 billion

Because the 80 % coverage eradicates malaria so
quickly in the model, the interpretation of the 5-year
model results becomes less interesting. For this reason,
the remainder of the results will be presented using the
original coverage percentages of 20, 40 and 60 %, except
where otherwise indicated.
E ect of budget

Previous work by Dimitrov et al. suggested that increasing the budget would decrease malaria deaths roughly
linearly up to a critical budget value, after which there
would be diminishing marginal bene t to additional
budget expenditures [11]. Using the baseline e cacy scenario, the optimization problem was solved sequentially
for budgets ranging from 15 million USD to 155 million

USD in increments of 10 million USD, and person-days
of malaria infection was plotted against budget. As seen
in Fig. 4, the model’s results are consistent with Dimitrov
et al. [11]. e person-days of malaria infection decrease
linearly with an increase in budget until roughly 55 million USD, after which diminishing marginal returns
on budget increases are observed. Moreover, beyond a
budget of 85 million USD, there can be no further reduction in person-days of malaria infection. Also shown in
Fig. 4 is the plot of person-days of malaria infection in
the baseline scenario when coverage up to 80 % is attainable. e graph exhibits the same general shape, but with
substantially lower values for the person-days of malaria
infection. Moreover, even with a very large budget, 60 %
coverage cannot achieve the low prevalence of malaria
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Table 4 Optimal 5-year (Y1 through Y5) sequences of interventions for the optimistic e cacy scenario
Geographic
region

Number of
districts

Initial
population state

Y1 intervention
(end pop. state)

Y2 intervention
(end pop. state)

Y3 intervention
(end pop. state)

Y4 intervention
(end pop. state)

Y5 intervention
(end pop. state)

(D, L)

500

(60, 15, 25)

LLIN_ACT 60 %

ACT 60 %

ACT 20 %

ACT 60 %

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

LLIN_ACT 60 %

ACT 40 %

ACT 40 %

ACT 20 %

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 60 %

ACT 60 %

ACT 40 %

ACT 60 %

ACT 40 %

(85, 5, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

LLIN_ACT 60 %

ACT_IRS60 %

None

ACT 40 %

None

(65, 5, 30)

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

LLIN_ACT 60 %

ACT_IRS60 %

None

ACT 20 %

ACT 40 %

(65, 5, 30)

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

LLIN_ACT 60 %

ACT_IRS60 %

ACT 60 %

None

ACT 40 %

(65, 5, 30)

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

LLIN 60 %

ACT_IRS60 %

ACT 60 %

None

ACT 40 %

(60, 5, 35)

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

None

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

(75, 10, 15)

IPT 40 %

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

(75, 10, 15)

None

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

(75, 10, 15)

None

None

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

IPT 40 %

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

(75, 10, 15)

None

IPT 20 %

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

None

IPT 40 %

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

None

None

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

IPT 40 %

None

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

IPT 40 %

IPT 40 %

LLIN_ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

(10, 15, 75)

(10, 15, 75)

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

(D, M)
(D, H)
(M, L)
(M, M)
(M, H)
(M, H)
(W, L)
(W, L)
(W, M)
(W, M)
(W, M)
(W, M)
(W, M)
(W, H)
(W, H)
(W, H)

500
500
500
500
266
234
497
3
324
172
2
1
1
498
1
1

(60, 15, 25)
(60, 15, 25)
(15, 15, 70)
(15, 15, 70)
(15, 15, 70)
(15, 15, 70)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)

Geographic region refers to the climate region and distribution cost pair, where the climate region is dry (D), moderate (M) or wet (W), and the distribution cost is low
(L), medium (M) or high (H). Number of districts refers to the number of districts that were assigned a given trajectory. Initial population state is the starting (S, I, R)
percentages of the region; the end population state for a given year is the resulting (S, I, R) state after distributing the corresponding intervention. The total persondays of malaria infection in this scenario is 2.977 billion

infection that 80 % coverage can achieve with even a
small budget.
Additionally, the qualitative change in the interventions chosen at di erent budget levels is evident in
Fig. 5. When the budget is 15 million USD, for instance,
most districts receive no intervention in most years.
ose that do receive 60 % coverage of ACT, either
alone or in combination with either IRS or LLIN, or
40 % coverage of IPT. (Although not shown in Fig. 5,
the raw results from the simulation reveal that the dry

regions receive interventions in year 1, which e ectively
eradicates malaria in those regions; most of the moderate climate regions receive interventions in most years,
with a cluster of high distribution cost districts receiving no intervention in any of the 5 years; and the wet
regions typically receive no intervention in most years).
When the budget is 85 million USD, Fig. 5 shows that
the number of districts receiving no intervention in
some year drops sharply. (A closer look at the raw
results reveals that all regions receive the maximum
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Low Distn. Cost, Dry Climate

Low Distn. Cost, Moderate Climate

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

1

2

3
Year

4

5

Medium Distn. Cost, Dry Climate
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
1

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
2

3
Year

4

5

2

3
Year

4

5

1

4

5

1

3
Year

4

5

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
2

3
Year

4

5

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
3
Year

2

Medium Distn. Cost, Wet Climate

1

High Distn. Cost, Moderate Climate

ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None
2

1

Medium Distn. Cost, Moderate Climate
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

High Distn. Cost, Dry Climate

1

1

Low Distn. Cost, Wet Climate

2

3
Year

4

5

High Distn. Cost, Wet Climate
ACT 60%
ACT_IRS 60%
IPT 20%
IPT 40%
IPT 60%
LLIN 20%
LLIN_ACT 20%
LLIN_ACT 60%
None

2

3
Year

4

5

1

2

3
Year

4

5

Fig. 3 Sequence of interventions over a 5-year time horizon in the pessimistic e cacy scenario. The thickness of each line is proportional to the
number of districts assigned a given sequence. Intervention sequences assigned to only a single district have been omitted from the gure ( ve
districts omitted in total). The total person-days of malaria infection in this scenario is 5.080 billion

of 60 % coverage of ACT in combination with IRS in
all years, except for the dry regions, which receive no
intervention in years 2 through 5 after malaria has been
e ectively eradicated).
Figure 6 shows the percentage of the total population that is in the infected class at the end of each of the
5 years, when the annual budget is 15 million USD as
compared to 85 million USD. A 15 million USD annual
budget achieves a drop from 15 % infected to around
8 % infected in steady state. An 85 million USD annual
budget achieves an initial drop to around 3 % infected,
which levels out to 5 % infected in steady-state. (Note
that this contrasts with the results shown previously in
Table 6 where if coverage of 80 % is attainable, malaria is
eradicated with only a 33.75 million USD budget).

Role of vaccine

e authors were surprised to observe that in all of the
simulations across geographic regions, e cacy scenarios, maximum coverage, and budgets, the vaccine is
almost never chosen, either alone or in combination with
IPT. Although the annual cost per treated person is quite
high (20.66 USD), the fact that it is distributed only to
children under the age of four, comprising an estimated
14.6 % of the population, makes its district-wide cost on
par with that of the other interventions. e model can
be used to understand under what conditions a malaria
vaccine would be a cost-e ective intervention by systematically lowering its cost and increasing its e cacy.
Speci cally, the optimization model was solved on all
1
,
combinations of bt = 0.001, 0.005, or 0.009, γt = 21 , 5.5
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Table 5 Optimal 5-year (Y1 through Y5) sequences of interventions for the pessimistic e cacy scenario
Geographic
region

Number of
districts

Initial
population state

Y1 intervention
(end pop. state)

Y2 intervention
(end pop. state)

Y3 intervention
(end pop. state)

Y4 intervention
(end pop. state)

Y5 intervention
(end pop. state)

(D, L)

500

(60, 15, 25)

ACT 60 %

None

None

None

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 60 %

None

None

None

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 60 %

None

None

None

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 60 %

ACT_IRS60 %

ACT_IRS60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

(70, 10, 20)

(70, 10, 20)

ACT 60 %

ACT_IRS60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(60, 5, 35)

(80, 5, 15)

(75, 10, 15)

(70, 10, 20)

(70, 10, 20)

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(65, 5, 30)

(75, 10, 15)

(70, 10, 20)

(70, 10, 20)

(70, 10, 20)

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(65, 5, 30)

(75, 10, 15)

(70, 10, 20)

(70, 10, 20)

(70, 10, 20)

None

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

IPT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

None

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

IPT 40 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

None

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

LLIN_ACT 60 %

(10, 15, 75)

(60, 5, 35)

(60, 10, 30)

(60, 10, 30)

(60, 10, 30)

None

None

LLIN 20 %

None

None

(10, 15, 75)

(10, 15, 75)

(20, 10, 70)

(5, 15, 80)

(10, 15, 75)

None

LLIN 20 %

None

None

None

(10, 15, 75)

(20, 10, 70)

(5, 15, 80)

(10, 15, 75)

(10, 15, 75)

LLIN 20 %

None

IPT 40 %

LLIN 20 %

LLIN_ACT 60 %

(20, 10, 70)

(5, 15, 80)

(10, 15, 75)

(20, 10, 70)

(55, 10, 35)

None

IPT 60 %

LLIN 20 %

None

None

(10, 15, 75)

(10, 15, 75)

(20, 10, 70)

(5, 15, 80)

(10, 15, 75)

None

LLIN 20 %

None

IPT 40 %

IPT 60 %

(10, 15, 75)

(20, 10, 70)

(5, 15, 80)

(10, 15, 75)

(10, 15, 75)

None

None

IPT 60 %

LLIN 20 %

IPT 20 %

(10, 15, 75)

(10, 15, 75)

(10, 15, 75)

(20, 10, 70)

(10, 15, 75)

None

IPT 60 %

LLIN 20 %

None

LLIN_ACT 20 %

(10, 15, 75)

(10, 15, 75)

(20, 10, 70)

(5, 15, 80)

(25, 10, 65)

None

LLIN 20 %

None

IPT 40 %

None

(10, 15, 75)

(20, 10, 70)

(5, 15, 80)

(10, 15, 75)

(10, 15, 75)

(D, M)
(D, H)
(M, L)
(M, L)
(M, M)
(M, H)
(W, L)
(W, L)
(W, L)
(W, M)
(W, M)
(W, H)
(W, H)
(W, H)
(W, H)

500
500
494
6
500
500
464
35
1
499
1
241
140
109
3

(60, 15, 25)
(60, 15, 25)
(15, 15, 70)
(15, 15, 70)
(15, 15, 70)
(15, 15, 70)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)
(10, 15, 75)

(W, H)

2

(10, 15, 75)

(W, H)

2

(10, 15, 75)

(W, H)
(W, H)
(W, H)

1
1
1

(10, 15, 75)
(10, 15, 75)
(10, 15, 75)

Geographic region refers to the climate region and distribution cost pair, where the climate region is dry (D), moderate (M) or wet (W), and the distribution cost is low
(L), medium (M) or high (H). Number of districts refers to the number of districts that were assigned a given trajectory. Initial population state is the starting (S, I, R)
percentages of the region; the end population state for a given year is the resulting (S, I, R) state after distributing the corresponding intervention. The total persondays of malaria infection in this scenario is 5.080 billion

1
or 30
, and vaccine cost = 2, 5, 10, or 20.66 USD per
person annually. Preliminary analysis of these results
showed little in uence of either bt or γt on the number

of times vaccine was selected; for most combinations of
bt and γt, vaccine will be frequently chosen if the cost
is 2 or 5 USD and will rarely be chosen if the cost is 10
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Table 6 Optimal 5-year (Y1 through Y5) sequences of interventions for the baseline e cacy scenario when the maximum
coverage available for each intervention is 80 %
Geographic
region

Number of
districts

Initial
population state

Y1 intervention
(end pop. state)

Y2 intervention
(end pop. state)

Y3 intervention
(end pop. state)

Y4 intervention
(end pop. state)

Y5 intervention
(end pop. state)

(D, L)

500

(60, 15, 25)

ACT 80 %

ACT 60 %

None

ACT 40 %

ACT 40 %

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 80 %

ACT 80 %

ACT 80 %

ACT 40 %

ACT 60 %

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 80 %

None

ACT 80 %

ACT 40 %

None

(90, 0, 10)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 80 %

None

ACT 80 %

ACT 80 %

None

(75, 0, 25)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

ACT 80 %

ACT 40 %

ACT 60 %

ACT 80 %

ACT 40 %

(75, 0, 25)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

IPT 40 %

LLIN_ACT 80 %

ACT 40 %

ACT 80 %

None

(20, 15, 65)

(80, 0, 20)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

ACT 80 %

ACT 60 %

ACT 40 %

None

None

(75, 0, 25)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

None

LLIN_ACT 80 %

ACT 40 %

ACT 80 %

None

(15, 20, 65)

(80, 0, 20)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

LLIN_ACT 80 %

None

ACT 40 %

ACT 80 %

ACT 80 %

(75, 0, 25)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(100, 0, 0)

None

ACT_IRS80 %

None

ACT 60 %

ACT 60 %

(10, 15, 75)

(80, 0, 20)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

None

ACT_IRS80 %

ACT 40 %

ACT 40 %

None

(10, 15, 75)

(80, 0, 20)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

None

LLIN_ACT 80 %

None

ACT 40 %

None

(10, 15, 75)

(75, 0, 25)

(95, 0, 5)

(100, 0, 0)

(100, 0, 0)

(D, M)
(D, H)
(M, L)
(M, M)
(M, H)
(M, H)
(M, H)
(W, L)
(W, M)
(W, H)
(W, H)

500

(60, 15, 25)

500

(60, 15, 25)

500

(15, 15, 70)

500

(15, 15, 70)

404

(15, 15, 70)

92

(15, 15, 70)

3

(15, 15, 70)

500

(10, 15, 75)

500

(10, 15, 75)

354

(10, 15, 75)

146

(10, 15, 75)

Infec ons
(billions of person-days over 5 years)

Geographic region refers to the climate region and distribution cost pair, where the climate region is dry (D), moderate (M) or wet (W), and the distribution cost is low
(L), medium (M) or high (H). Number of districts refers to the number of districts that were assigned a given trajectory. Initial population state is the starting (S, I, R)
percentages of the region; the end population state for a given year is the resulting (S, I, R) state after distributing the corresponding intervention. The total persondays of malaria infection in this scenario is 1.139 billion, and in all geographic regions, malaria is eradicated over the 5-year time horizon
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Fig. 5 Interventions chosen (in district-years) under a 15 million USD annual budget as compared to an 85 million USD annual budget, aggregated
over all geographic regions and a 5-year time horizon in the baseline e cacy scenario
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Fig. 6 Percentage of the population in the infected class over time
under a 15 million USD annual budget (solid line) as compared to
an 85 million USD annual budget (dashed line), aggregated over all
geographic regions, in the baseline e cacy scenario

or 20.66 USD. erefore, it can be concluded that cost
is a driving factor in the choice to select vaccines over
other interventions. Figure 7 shows the number of districts receiving vaccine, either alone or in combination
with IPT, over the 5-year time horizon as a function of
vaccine cost, for the baseline e cacy scenario and using
1
bt = 0.005, and γt = 5.5
. When the vaccine cost is 2 USD
per person, it is selected quite often, but is selected far
less frequently when the cost is 5 USD. Moreover, it is
almost never selected at a cost of 10 or 20.66 USD.
Shown in the same gure is the person-days of malaria
infection in those same instances. Reducing the vaccine
cost from 20.66 USD per person to 2 USD per person
yields only a 1.5 % reduction in person-days of malaria
infection, from 4.51 billion to 4.44 billion.

An important motivation underlying this work is the idea
that distributing an intervention changes the malaria
transmission dynamics, which could a ect future intervention choices. Figure 8 compares the interventions
chosen in the rst year of the 5-year time horizon to
those chosen if the time horizon is only a single year. As
mentioned above, in the rst year of the 5-year time horizon, resources are focused primarily on the dry and moderate climate regions that receive either ACT alone at
60 % coverage, or ACT in combination with LLIN at 60 %
coverage. Most of the medium-to-high distribution cost
districts in the wet regions receive no treatment during
year 1. Nearly 400 of the low distribution cost districts in
the wet regions get 20 % coverage of LLIN with ACT, and
the remaining 100 get 60 % coverage of LLIN with ACT.
By contrast, if only a 1-year time horizon is used, the
solution changes. Dry regions (at all distribution costs)
again receive ACT alone at 60 % coverage. Moderate climate regions having low or medium distribution costs
receive LLIN in combination with ACT at 60 % coverage,
as do 324 moderate climate regions having high distribution costs. However, now 175 moderate climate districts
having high distribution costs drop down to no intervention, and in return, all 500 wet climate districts having
low distribution costs receive LLIN with ACT at 60 %
coverage, which is substantially higher than before. us,
incorporating a multi-year planning horizon that anticipates changes in the malaria transmission as a result of
the interventions distributed does indeed a ect the optimal choice of intervention.
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Fig. 7 Vaccine selection (in number of district-years) and person-days of malaria infection versus vaccine cost, over 5-year time horizon, in the
baseline e cacy scenario
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Fig. 8 First-year interventions chosen in a 1-year time horizon versus a 5-year time horizon, by climate region, in the baseline e cacy scenario

Role of climate

ere is a noticeable qualitative di erence in the types
of treatments distributed to the three climate regions

considered. Aggregating over all years and distribution
cost categories for the baseline e cacy scenario, the rst
row of Fig. 9 shows the number of districts receiving
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Fig. 9 Interventions chosen by climate region when vaccine cost is 20.66 USD per treated person versus a low-cost vaccine having cost 2 USD per
treated person, in the baseline e cacy scenario

each type of treatment, separated by climate region. Dry
regions are adequately served by ACT alone; moderate
regions require ACT in combination with either LLIN
or IRS; and wet regions get LLIN alone, LLIN with ACT,
ACT with IRS, and a handful of others (though as discussed earlier, this variety is likely the result of the model
using the available budget because no treatment at 60 %
coverage is very successful at reducing malaria in the wet
regions).
If a lower-cost vaccine is available at 2 USD per person
per year, the second row of Fig. 9 shows that dry regions
again receive exclusively no intervention and ACT, and
moderate regions again receive exclusively ACT in combination with either IRS or LLIN. Now, however, in the
wet regions, the number of years of “no intervention”
drops signi cantly, from 2725 to 70, and vaccine use, at
either 40 or 60 % coverage, comprises nearly 50 % of the
pie chart.
e takeaway messages are that a single choice of intervention across all climate types is unlikely to be optimal,
and that the development of a low-cost malaria vaccine is
likely to be of greatest use in regions with high mosquito
densities; drier areas are better served by ACT, alone or
in combination with IRS and LLIN.

Conclusions
Because the model is very sensitive to the disease transmission parameter values used, it is best suited for qualitative
interpretations about relative bene ts of certain interventions. For instance, while common sense might suggest that
intervention resources should be focused on wet climate
regions with high mosquito counts, the results of the simulations with a maximum coverage of 60 % suggest the opposite: to reduce person-days of malaria infection, it might
be better to invest resources on areas where interventions
can dramatically reduce the prevalence of malaria, rather
than expend resources on areas where malaria is likely to
persist, despite best e orts. But if coverage closer to 80 %
is attainable, then malaria can be combatted in wet climate
regions. Likewise, the model can illustrate the sensitivity of
the optimal policy to certain parameters. For example, the
optimal sequence of interventions varies by climate type (as
represented by mosquito density), suggesting that a onesize- ts-all approach to malaria eradication is not optimal.
e sensitivity of the model to parameter assumptions also
signals that prior to using the model to guide policy in any
given region, the choice of parameter values would rst
need to be calibrated to match known malaria prevalence
rates in the region.
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Future re nements of the model could address
acquired resistance to interventions, age-dependent
immunity, spatial e ects of human or mosquito migration, and computational tractability. Drug resistance
in malaria parasites and insecticide resistance in mosquitoes are major challenges to control and eradication
e orts [41– 43]. Implementing resistance in this model
would require tracking decreased e ectiveness of treatment after use in multiple consecutive years. is would
increase the computational challenge of solving the
model, however, as the costs and bene ts of choosing
a particular intervention in a given year would depend
not only on the (S, I, R) population state but also on the
sequence of interventions chosen in prior years. Likewise, incorporating age-dependent immunity or spatial
e ects would also require an increase in the number
of population compartments in the (S, I, R) model.
Already, computational power was limited, even using
a 5 % population resolution. e bottleneck appears to
be in the formulation of the ILP using AMPL. Although
the data le is only 2 MB at 5 % resolution and 11 MB
at 2 % resolution, loading the 5 % resolution data le
into AMPL took approximately 15 min on a 32-core,
128 GB RAM parallel compute server located in the
Harvey Mudd College Mathematics Department, and
attempting to load the data le for the 2 % resolution
case exceeded the available 128 GB of RAM on the
server. Once loaded, the 5 % resolution model was subsequently solved by the CPLEX solver within seconds.
e technical sta at the NEOS server (an online server
for optimization solvers on which earlier tests were
run [44– 46]) who are familiar with these modelling
languages suggested using a more e cient modelling
language than AMPL for formulating the optimization
model; this is left as future work.
Given the growing interest in malaria eradication, the
WHO Global Malaria Programme cites the need for
operations research studies to determine the best intervention strategies in areas where transmission dynamics
are changing as malaria is being eliminated.
ey also
present a list of priority research questions that includes
questions about safety, access, and community involvement [2]. is paper presents a exible modelling framework that can guide such decisions. e model permits a
multi-year planning horizon over areas characterized by
disparate infrastructure and climate. Given inputs of the
per-person cost of each intervention and the e ects each
intervention has on malaria disease transmission parameters, the model provides a sequence of interventions
over a xed time horizon that minimizes person-days of
malaria infection subject to an annual budget. Moreover, this model can be adapted to the treatment of other
infectious diseases.
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